- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Albert Einstein Radiation Biology & Molecular-Immune Therapeutics
Albert Einstein Radiation Biology & Molecular-Immune Therapeutics is listed as an academic core research supplier in the Scientist.com network, with 1 site in 1 country.
View Albert Einstein Radiation Biology & Molecular-Immune Therapeutics on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Academic core
Biomarkers
- Colony Forming Cell Assay Examine ability of hematopoietic stem cells to form colonies in vitro.
- Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
Cell Culture and Characterization
- Microsatellite Instability Analysis Compare allelic profiles and detect genomic instability.
Chemical and Compound Analysis
- Computed Tomography Visualize the internal features of solid objects.
Disease Models
- Xenografts Evaluate drug candidate in tissue graft or organ transplant model.
Human Biological Samples
- Human Organoids Test immuno-oncology drugs and therapies on fresh, unpropagated 3D tumor organoids to evaluate efficacy and understand drug mechanism of action. Understand the intact tumor immune microenvironment, cytotoxic efficacy...
In Vitro Assays
- ImmunoSEQ Assay Unmask the identity of millions of T- and B-cell receptors in a single sample using bias-controlled multiplex PCR amplification, high-throughput sequencing, and sophisticated bioinformatics.
In Vitro Pharmacology
- Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Assays Use biochemical, cell based or in vivo assays to measure CTLA-4 receptor activity.
- Extracellular signal Regulated Kinase Assays Use biochemical, cell based or in vivo assays to measure ERK enzyme activity.
- HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
- Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
- Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
- In Vitro Oncology Models Use cell-based and biochemical models of cancer.
Show all 12 in In Vitro Pharmacology
- Mammalian Target of Rapamycin Complex Assays Use biochemical, cell based or in vivo assays to measure mTORC enzyme activity.
- Phosphatidylinositol 3-Kinase (PI3K) Assays Use biochemical, cell based or in vivo assays to measure PI3K enzyme activity.
- Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
- Programmed Death-Ligand 2 (PD-L2) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of PD-L2 ligand.
- RAS Assays Use biochemical, cell based or in vivo assays to measure RAS enzyme activity.
- Vascular Endothelial Growth Factor (VEGF) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of VEGF ligand.
Show all 28 services
Model Development
- Pre-clinical Animal Surgery Conduct surgey in animals used as pre-clinical models.
Oncology Models
- Angiogenesis Models Measure therapeutic endpoints in animal models of angiogenesis.
- Experimental Metastatic Models Measure therapeutic endpoints in animal models of experimental metastatic cancer.
- Immuno-PDX Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
- Oncology Derived PDX Patient derived xenografts derived from various oncological samples. This includes, but is not limited to, samples from Lymphoma, Melanoma, and Leukemia.
- Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
- Oncology Xenografts Xenografts derived from oncological samples.
Show all 8 in Oncology Models
- Ovarian Cancer Mouse Measure therapeutic endpoints in animal models of ovarian cancer.
- Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
Work with Albert Einstein Radiation Biology & Molecular-Immune Therapeutics on Scientist.com
For prices, more details, or to contact Albert Einstein Radiation Biology & Molecular-Immune Therapeutics, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.